[EFFECT] CATALYST PHARMACEUTICALS, INC. SEC Filing

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/17/2026 - 06:05 AM Accepted by SEC EDGAR 07/17/2026 - 12:15 AM Learn about SEC filing dates

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	July 16, 2026

Accession Number:

0001193125-26-305088

Submission Type:

POS AM

CIK:	0001369568
Company Name:	CATALYST PHARMACEUTICALS, INC.
File Number:	333-240052